273 related articles for article (PubMed ID: 23118010)
21. Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis.
Gengenbacher M; Xu T; Niyomrattanakit P; Spraggon G; Dick T
FEMS Microbiol Lett; 2008 Oct; 287(1):128-35. PubMed ID: 18680522
[TBL] [Abstract][Full Text] [Related]
22. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
Rao GS; Kumar M
Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of
Parvez MM; Shin HJ; Jung JA; Shin JG
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223391
[No Abstract] [Full Text] [Related]
24. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
Vinnicombe HG; Derrick JP
Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
[TBL] [Abstract][Full Text] [Related]
25. 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
Dennis ML; Lee MD; Harjani JR; Ahmed M; DeBono AJ; Pitcher NP; Wang ZC; Chhabra S; Barlow N; Rahmani R; Cleary B; Dolezal O; Hattarki M; Aurelio L; Shonberg J; Graham B; Peat TS; Baell JB; Swarbrick JD
Chemistry; 2018 Feb; 24(8):1922-1930. PubMed ID: 29171692
[TBL] [Abstract][Full Text] [Related]
26. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
[TBL] [Abstract][Full Text] [Related]
27. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Analysis of Bacterial Folate Metabolism Intermediates and Antifolates.
Dawadi S; Kordus SL; Baughn AD; Aldrich CC
Org Lett; 2017 Oct; 19(19):5220-5223. PubMed ID: 28926267
[TBL] [Abstract][Full Text] [Related]
29. A combination screening to identify enhancers of para-aminosalicylic acid against Mycobacterium tuberculosis.
Heo J; Koh D; Woo M; Kwon D; de Almeida Falcão VC; Wood C; Lee H; Kim K; Choi I; Jang J; Brodin P; Shum D; Delorme V
Sci Rep; 2022 Apr; 12(1):5635. PubMed ID: 35379873
[TBL] [Abstract][Full Text] [Related]
30. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
31. Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates.
Thiede JM; Kordus SL; Turman BJ; Buonomo JA; Aldrich CC; Minato Y; Baughn AD
Sci Rep; 2016 Dec; 6():38083. PubMed ID: 27905500
[TBL] [Abstract][Full Text] [Related]
32. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
Cheng YS; Sacchettini JC
Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
[TBL] [Abstract][Full Text] [Related]
33. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
[TBL] [Abstract][Full Text] [Related]
34. Reactive dirty fragments: implications for tuberculosis drug discovery.
Gopal P; Dick T
Curr Opin Microbiol; 2014 Oct; 21():7-12. PubMed ID: 25078318
[TBL] [Abstract][Full Text] [Related]
35. [Effect of PAS on metabolism in Mycobacterium tuberculosis].
WESTFAL I
Med Dosw Mikrobiol; 1952; 4(3):405-6. PubMed ID: 13002061
[No Abstract] [Full Text] [Related]
36. dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.
Moradigaravand D; Grandjean L; Martinez E; Li H; Zheng J; Coronel J; Moore D; Török ME; Sintchenko V; Huang H; Javid B; Parkhill J; Peacock SJ; Köser CU
Antimicrob Agents Chemother; 2016 Jun; 60(6):3864-7. PubMed ID: 27021327
[No Abstract] [Full Text] [Related]
37. [Effects of antibiotics and chemotherapeutics on mycobacterium tuberculosis typus humanus in incubated chicken eggs; effect of PAS on mycobacterium tuberculosis typus humanus].
KLOSE F; KNOTHE H
Arztl Wochensch; 1952 Jun; 7(26):598-601. PubMed ID: 12976248
[No Abstract] [Full Text] [Related]
38. Association between mutations in a
Zeng R; He L; Zhang B; Hu Y; Yu J; Yang S; Gu J; Wu Z; Deng J
Emerg Microbes Infect; 2023 Dec; 12(2):2276339. PubMed ID: 38029724
[TBL] [Abstract][Full Text] [Related]
39. Genetic determinants involved in p-aminosalicylic acid resistance in clinical isolates from tuberculosis patients in northern China from 2006 to 2012.
Zhang X; Liu L; Zhang Y; Dai G; Huang H; Jin Q
Antimicrob Agents Chemother; 2015 Feb; 59(2):1320-4. PubMed ID: 25421465
[TBL] [Abstract][Full Text] [Related]
40. Determination of critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against para-aminosalicylic acid with clinical isolates with thyA, folC and dfrA mutations.
Wang W; Li S; Ge Q; Guo H; Shang Y; Ren W; Wang Y; Xue Z; Lu J; Pang Y
Ann Clin Microbiol Antimicrob; 2022 Nov; 21(1):48. PubMed ID: 36335391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
